Clopidogrel - Bone marrow and peripheral blood stem cell

Essential information

Obligatory

Must not donate.

Discretionary

If prescribed for primary prevention of cardiovascular disease, discuss with Designated Clinical Support Officer.

Supporting information

Additional information

Clopidogrel is an antiplatelet drug which is used in the treatment and secondary prevention of cardiovascular disease and stroke. In this case, the underlying condition would be a contraindication to donation, in the interests of donor safety.

Occasionally, clopidogrel is used for primary prevention in patients who are intolerant of or hypersensitive to aspirin. Donor needs to be assessed by the Designated Clinical Support Officer for the suitability of withholding clopidogrel for the relevant procedure.

Reason for change:

This is a new entry.

Version details:

BM-DSG Edition 203 Release 47 (31 May 2022)